Payden & Rygel
- SEC CIK
- 0000919219
- Latest filing
- Jul 31, 2026
CVS holding history
CVS Health Corp in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CVS overviewAll 13F holders of CVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 218,700
- Value
- $22.6M
- % of portfolio
- 1.7%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 218,700 | $22.6M | 1.7% | +5,600+2.6% | Added | Holders |
| Q1 2026 | 213,100 | $15.3M | 1.2% | −47,100−18.1% | Reduced | Holders |
| Q4 2025 | 260,200 | $20.6M | 1.4% | −1,300−0.5% | Reduced | Holders |
| Q3 2025 | 261,500 | $19.7M | 1.7% | +261,500 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −99,900−100.0% | Sold out | Holders |
| Q3 2024 | 99,900 | $6.28M | 0.5% | +99,900 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −183,500−100.0% | Sold out | Holders |
| Q1 2024 | 183,500 | $14.6M | 1.0% | −135,500−42.5% | Reduced | Holders |
| Q4 2023 | 319,000 | $25.2M | 1.8% | +35,600+12.6% | Added | Holders |
| Q3 2023 | 283,400 | $19.8M | 1.6% | +182,000+179.5% | Added | Holders |
| Q2 2023 | 101,400 | $7.01M | 0.5% | +97,300+2,373.2% | Added | Holders |
| Q1 2023 | 4,100 | $305.0K | <0.1% | −432,100−99.1% | Reduced | Holders |
| Q4 2022 | 436,200 | $40.6M | 2.2% | +29,000+7.1% | Added | Holders |
| Q3 2022 | 407,200 | $38.8M | 2.3% | +8,700+2.2% | Added | Holders |
| Q2 2022 | 398,500 | $36.9M | 2.2% | +821+0.2% | Added | Holders |
| Q1 2022 | 397,679 | $40.2M | 2.0% | −114,700−22.4% | Reduced | Holders |
| Q4 2021 | 512,379 | $52.9M | 2.4% | −2,200−0.4% | Reduced | Holders |
| Q3 2021 | 514,579 | $43.7M | 2.3% | +235,300+84.3% | Added | Holders |
| Q2 2021 | 279,279 | $23.3M | 1.1% | −147,837−34.6% | Reduced | Holders |
| Q1 2021 | 427,116 | $32.1M | 1.5% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.